China Universal Asset Management »

Enliven Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $213k 10k 20.47
2025-06-30 $198k 9.9k 20.06
2025-03-31 $193k 9.8k 19.68
2024-12-31 $233k 10k 22.50
2024-09-30 $232k 9.1k 25.54
2024-06-30 $129k 5.5k 23.37
2024-03-31 $140k 8.0k 17.59
2023-12-31 $66k 4.8k 13.84

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Commodore Capital
Fairmount Funds Management
BlackRock
VR Adviser
Polar Capital Holdings
Vanguard Group
Henderson Group
Novo A/S
Pictet Asset Management Holding SA
Blackstone Group
Capital Research Global Investors
Citadel Advisors
Vestal Point Capital

View all funds holding Enliven Therapeutics